Skip to main content
Biomedical Reports logoLink to Biomedical Reports
. 2016 Feb 22;4(4):403–407. doi: 10.3892/br.2016.607

Role of physical exercise in Alzheimer's disease

WEI-WEI CHEN 1, XIA ZHANG 1, WEN-JUAN HUANG 1,
PMCID: PMC4812200  PMID: 27073621

Abstract

The benefits of physical exercise on the brain and general wellness are well recognised, but not particularly well known to the general public. Understanding the importance of integrating active behavior for overall health is crucial at any age and particularly for the elderly who are at risk of developing Alzheimer's disease (AD), a disease mainly affecting individuals aged >65 years. AD is a neurodegenerative disease characterized by extracellular senile plaques of amyloid-β, intracellular neurofibrillary tangles of the protein tau, brain atrophy and dementia. The beneficial effects of physical exercise have been observed on the maintenance of brain size and efficiency for the prevention of AD risks, such as obesity, hypertension and stroke. These effects are extended to individuals with, or at risk of dementia and other age-related neurodegenerative disorders. Accordingly, although extensive studies are required to fully understand the mechanisms by which physical exercise procures beneficial effects, data suggest the relevance of integrating physical exercise in the prevention and/or cure of AD, disease whose incidence is predicted to increase in the future. Such an increase, may pose medical, social and economical challenges for populations and the health care system worldwide. In the present review we assess the positive aspects of physical exercise with regard to prevention and cure of AD.

Keywords: physical exercise, Alzheimer's disease, dementia, wellness

1. Introduction

Regular exercise including jogging, walking, biking, stretching, swimming and skipping may prevent and/or retard the progression of brain disorder and metabolic diseases such as obesity, diabetes and hypertension, which are risk factors of diseases affecting the brain (1). Regular physical exercise enhances the endurance of cells, tissues and organs to oxidative stress (2), increase energy metabolism (3), vascularization (4) as well as neurotrophin synthesis (5), all of which constitute important inducers of neurogenesis, muscle development, memory improvement and brain plasticity. These benefits are important in the prevention of Alzheimer's disease (AD) and provide treatment options for age-associated neurodegenerative disorders such as AD (6).

High-intensity training is more effective in women than in men after six months of training (7) and is associated with an increase in functional cognitive faculties, glucose metabolism, cardiorespiratory fitness and body composition (7). Furthermore, when the regular or high-intensity trainings are reinforced or replaced by resistance training or strength training (8), such as walking and moving around the house, climbing stairs, getting up from the floor and putting on socks daily or ≥2 days per week at a moderate intensity of ≥50% of one's maximum, there are long-term effects on brain health. For other causes of dementia, previous studies have reported an almost 37% reduction of the risk (9). These types of training particularly increase muscle mass in the human body and have beneficial effects on metabolic ageing (10). Loss of muscle mass has been identified in individuals at risk or diagnosed with AD (11,12). In concordance with the abovementioned data, a strong correlation between greater muscle strength and a low risk of developing dementia or AD in healthy individuals has been identified (13). Additionally, the abovementioned data suggest that practicing physical activity routinely throughout a subject's lifetime, at any age and especially for older adults, constitutes a strategy for increasing overall health and risks involved in the development of dementia and AD (9). Thus, engaging in such activity may reduce the wide range of individuals with neurological conditions. However, the benefits of exercise on brain health and wellness are poorly studied and the general public is unfamiliar with these benefits.

In this review, we evaluated aspects by which physical activity procures beneficial preventive or curative effects on AD and other age-associated neurogenerative diseases.

2. Alzheimer's disease

Ageing is a risk factor of cognitive function impairment and dementia including AD, which is characterized by the extracellular deposition of senile plaques of amyloid-β (Aβ), intracellular neurofibrillary tangles of protein tau, brain atrophy and dementia (14). Aβ-induced mitochondrial dysfunction has been associated with inhibition of the production of ATP (1518) and the reduction of the activities of key enzymes of oxidative stress metabolism such as α-ketoglutarate dehydrogenase complex, pyruvate dehydrogenase complex and cytochrome oxidase. In addition, Aβ-induced reduced complex IV activity in mitochondria of the hippocampus and platelets (19) and the dysfunction of calcium homeostasis thereby increasing the accumulation of mitochondrial calcium that contribute to the decreased reuptake of calcium (20), leading to the translocation of pro-apoptotic molecules from mitochondria to cytosol and apoptosis, which results in increased activity of calmodulin-dependent kinase and calpain (17,21). Aβ-induced also increased the mutations of mitochondrial DNA (18,22). Together with Aβ, intracellular neurofibrillary tangles favour the excessive accumulation of reactive oxygen species (ROS) due to mitochondrial dysfunction which increases oxidative stress (19) leading to increased levels of lipid peroxidation, protein oxidation and DNA/RNA oxidation (23) thereby causing neurodegeneration and cerebral amyloid angiopathy (CAA). ROS can also aggravate the production and aggregation of Aβ and promote the phosphorylation of tau, thus establishing a vicious cycle of pathogenesis in AD (15).

Another risk factor associated with ageing is the increase of small vascular diseases (SVD) (24), a set of pathophysiology involving subcortical lesions, microinfarction, lacunas and intracerebral small vessels including arteries, arterioles, capillaries and small veins (25). Specifiallcy, unrelated to CAA, SVD is the most frequent vascular pathology in ageing in a healthy manner and AD brain. However, SVD alone or associated with AD has been considered as the major etiologic cause of morbidity, disability, and cognitive dysfunctions leading to dementia and mortality (26,27). Accordingly, several SVD, unrelated to atherosclerotic disease, are associated with inherited mutations (28) that result in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) (29,30). CARASIL is a single-gene encoding cell-signaling receptors instigating the degeneration of vascular smooth muscle in small arteries and arterioles, caused by mutations in the HTRA1 gene encoding HtrA serine peptidase/protease 1 (29). Aberrant HTRA1 activity, results in increased transforming growth factor (TGF)-β1 signaling provoking multiple actions including vascular fibrosis and extracellular matrix (ECM) synthesis (29,30). TGF-β1 is increased in AD and is associated with the release of pro-inflammatory cytokines interleukin-1β and tumor necrosis factor-α, and results in the initiation and/or the propagation of a destructive inflammatory cycle in astroglial cells and neuronal apoptosis together with the development of vascular hypertrophy, fibrosis, and the accumulation of ECM components (3135), which result in the decrease of brain perfusion and cerebral glucose metabolism. These reductions are also associated with the decrease in the neuronal expression of genes encoding subunits of the mitochondrial electron transporter chain (36).

3. Beneficial effects of physical exercise on Alzheimer's disease

Although there is a lack of consensus regarding optimal physical activities associated with AD prevention or improvement, aerobic activities (3741) and balanced training of moderate-to-severe intensities are considered optimal (42). A meta-analysis suggested that although exercise has a positive effect on cognitive performance, cardiovascular fitness alone (VO2 Max) does not explain these benefits (43). However, the regular practice of walking improves cognition in AD (44,45), while strength training is particularly more effective for improving postural and motor function, and reducing the risk of developing AD (46), since it improves muscle mass and strength, shown to be affected in AD patients (10). In addition, environmental conditions such as bright light exposure and good nutrition may play an important role in improving training results (47,48). Accordingly, the meta-analysis identified the preventive effects of physical activities against AD.

The majority of longitudinal epidemiological studies have clearly shown associations between physical activities and the risk of cognitive decline in a dose-response manner (49,50), suggesting that physical activities may delay the onset of AD as well as the risk of cognitive decline (5158) and mortality (59). The reduction of depression symptomatology (6062), improvements in postural, motor functions (63,64) and the reduction of Aβ plaques as shown in a mouse model in which mice were required to run in the wheel have also been identified (65,66). The reduction of Aβ referred to neuroprotective mechanisms. Specifically, 40 min of physical activities such as the ergocycle, treadmill and stair-climbing activities over a period of 12 consecutive weeks, has been associated with an increase of cerebral blood flow that improves neurogenesis (67) in brain areas, including dentate gyrus of the hippocampus. The beneficial effects on cerebral blood flow have been associated with the reduction of cerebrovascular and endothelial dysfunction pathophysiology by improvement through the activation of nitric oxide (NO)/endothelial NO synthase (eNOS), resulting in the building of vascular reserve and the maintenance of neuronal plasticity (68). In addition, an aerobic program session lasting 3 weeks for 1 h for a period of 6 months increased the volume of gray and white matters in the cortical regions of subjects >60 years (69). Similar data however, were not identified in anaerobic conditions (69).

In concordance with those data, physical activity has been found to counteract the noxious effects of oxidative stress in animal models in which the reduction of oxidative stress was also associated with the reduction of cholesterol and insulin resistance, resulting in increasing vascularization and improving energy metabolism such as glucose metabolism (40,68,7072) and facilitating neurogenesis and synaptogenesis, which improve memory and cognitive functions (40,55,67,68,70,72). Accordingly, in old mouse models of AD trained with sedentary control mice, the hippocampal neurogenesis was associated with synaptogenesis and spatial memory improvements (71,73). Similarly, increases of the volume of hippocampus of >2% together with plasma concentration of brain-derived neurotrophic factor (BDNF) were also observed in older healthy subjects (74) and in individuals with AD (75) following one year of moderately intense aerobic exercise (3 days per week, 40 min per session). The increase in BDNF can be enhanced by the environmental condition. In mice trained in an enriched environment, cognitive improvements related to benefits from environmental enrichment were higher in BDNF, hippocampal neurotrophin and activation of hippocampal neurogenesis than those of mice in the same training program in poor environmental enrichment (66). Additionally, physical training was associated with the decrease of neurofibrillary degeneration and neuroinflammation as well as in the prevention against loss of the expression of choline acetyltransferase which is affected in mouse models of AD after 9 months of training (76,77). Of note, neurotrophins are proteins classically identified as mediators of neuronal survival and differentiation during development. They also maintain viability of neurons in adulthood, protecting, restoring neurons in response to injury and ageing. The efficacy of synaptic transmission is adaptable and neurotrophins serve as activity-dependent modulators of synaptic plasticity (78) in which BDNF has emerged as a key mediator in the memory centers of the brain (79). Notably, neurotrophins regulate target genes encoding structural proteins, enzymes or neurotransmitters resulting in the modification of neuronal morphology and function. These data are appropriate for prescription of physical activity for brain health although further investigations are required to identify reasonable standards and universal preventives and/or curative protocols for AD and related dementia.

4. Conclusion

Aerobic multicomponent training involving power and balance exercises induces important beneficial effects on health thereby improving the executive function, attentional capacity, processing speed, episodic memory and procedural memory (8082). Moderate and high intensities have demonstrated a neuroprotective effect through the production of antioxidant enzymes and growth factors such as superoxide dismutase, eNOS, BDNF, nerve growth factors, insulin-like growth factors and vascular endothelial growth factor and by reducing the production of ROS, neuroinflammation, the concentration of Aβ plaques in cognitive regions and tau pathology, leading to the improvement of cerebral blood flow, hyperemia, cerebrovascular reactivity and memory (68,70,83). Although extensive studies are required to understand mechanisms by which physical exercise procures beneficial effects to establish standard protocols, the practice of physical activity may be disregarded by a large number of people, particularly those at risk or suffering AD, or taking medication.

References

  • 1.Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, et al. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch Neurol. 2010;67:71–79. doi: 10.1001/archneurol.2009.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M. Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox Signal. 2013;18:1208–1246. doi: 10.1089/ars.2011.4498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.van Praag H, Fleshner M, Schwartz MW, Mattson MP. Exercise, energy intake, glucose homeostasis, and the brain. J Neurosci. 2014;34:15139–15149. doi: 10.1523/JNEUROSCI.2814-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gertz K, Priller J, Kronenberg G, Fink KB, Winter B, Schröck H, Ji S, Milosevic M, Harms C, Böhm M, et al. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res. 2006;99:1132–1140. doi: 10.1161/01.RES.0000250175.14861.77. [DOI] [PubMed] [Google Scholar]
  • 5.Zoladz JA, Pilc A. The effect of physical activity on the brain derived neurotrophic factor: From animal to human studies. J Physiol Pharmacol. 2010;61:533–541. [PubMed] [Google Scholar]
  • 6.Garuffi M, Costa JLR, Hernández SSS, Vital TM, Stein AM, dos Santos JG, Stella F. Effects of resistance training on the performance of activities of daily living in patients with Alzheimer's disease. Geriatr Gerontol Int. 2013;13:322–328. doi: 10.1111/j.1447-0594.2012.00899.x. [DOI] [PubMed] [Google Scholar]
  • 7.Bow C, Cheung C, Gao Y, Xiao S, Lau K, Soong C, Yeung S, Kung A. Bone mineral density and serum osteoprotegerin levels in pre-and post-menopausal women. Hong Kong Med J. 2011;17:9. [Google Scholar]
  • 8.American College of Sports Medicine: American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41:687–708. doi: 10.1249/MSS.0b013e3181915670. [DOI] [PubMed] [Google Scholar]
  • 9.Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498–504. doi: 10.1001/archneur.58.3.498. [DOI] [PubMed] [Google Scholar]
  • 10.Hurley BF, Hanson ED, Sheaff AK. Strength training as a countermeasure to aging muscle and chronic disease. Sports Med. 2011;41:289–306. doi: 10.2165/11585920-000000000-00000. [DOI] [PubMed] [Google Scholar]
  • 11.Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol. 2010;67:428–433. doi: 10.1001/archneurol.2010.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009;66:1339–1344. doi: 10.1001/archneurol.2009.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Taaffe DR, Irie F, Masaki KH, Abbott RD, Petrovitch H, Ross GW, White LR. Physical activity, physical function, and incident dementia in elderly men: The Honolulu-Asia Aging Study. J Gerontol A Biol Sci Med Sci. 2008;63:529–535. doi: 10.1093/gerona/63.5.529. [DOI] [PubMed] [Google Scholar]
  • 14.Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, et al. Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol. 2010;9:1118–1127. doi: 10.1016/S1474-4422(10)70223-4. [DOI] [PubMed] [Google Scholar]
  • 15.Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev. 2013;2013:316523. doi: 10.1155/2013/316523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res. 2002;70:357–360. doi: 10.1002/jnr.10389. [DOI] [PubMed] [Google Scholar]
  • 17.Zhang C, Rissman RA, Feng J. Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model. J Alzheimers Dis. 2015;44:375–378. doi: 10.3233/JAD-141890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kwiatkowski D, Czarny P, Galecki P, Bachurska A, Talarowska M, Orzechowska A, Bobińska K, Bielecka-Kowalska A, Pietras T, Szemraj J, et al. Variants of Base Excision Repair Genes MUTYH, PARP1 and XRCC1 in Alzheimer's Disease Risk. Neuropsychobiology. 2015;71:176–186. doi: 10.1159/000381985. [DOI] [PubMed] [Google Scholar]
  • 19.Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev. 2012;2012:428010. doi: 10.1155/2012/428010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ito E, Oka K, Etcheberrigaray R, Nelson TJ, McPhie DL, Tofel-Grehl B, Gibson GE, Alkon DL. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl Acad Sci USA. 1994;91:534–538. doi: 10.1073/pnas.91.2.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.da Silva, Oliveira GL, de Freitas RM. Potential involvement of oxidative stress in induction of neurodegenerative diseases: Actions, mechanisms and neurotherapeutic potential of natural antioxidants. Afr J Pharm Pharmacol. 2014;8:685–700. [Google Scholar]
  • 22.Gerenu G, Liu K, Chojnacki JE, Saathoff JM, Martínez-Martín P, Perry G, Zhu X, Lee HG, Zhang S. Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model. ACS Chem Neurosci. 2015;6:1393–1399. doi: 10.1021/acschemneuro.5b00082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid β-peptide. Trends Mol Med. 2001;7:548–554. doi: 10.1016/S1471-4914(01)02173-6. [DOI] [PubMed] [Google Scholar]
  • 24.Chamorro A, Pujol J, Saiz A, Vila N, Vilanova JC, Alday M, Blanc R. Periventricular white matter lucencies in patients with lacunar stroke. A marker of too high or too low blood pressure? Arch Neurol. 1997;54:1284–1288. doi: 10.1001/archneur.1997.00550220082018. [DOI] [PubMed] [Google Scholar]
  • 25.Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701. doi: 10.1016/S1474-4422(10)70104-6. [DOI] [PubMed] [Google Scholar]
  • 26.Aguero-Torres H, Kivipelto M, von Strauss E. Rethinking the dementia diagnoses in a population-based study: What is Alzheimer's disease and what is vascular dementia? A study from the kungsholmen project. Dement Geriatr Cogn Disord. 2006;22:244–249. doi: 10.1159/000094973. [DOI] [PubMed] [Google Scholar]
  • 27.Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75–80. doi: 10.1016/j.jns.2004.09.019. [DOI] [PubMed] [Google Scholar]
  • 28.Mutrux S. Contribution to the differential histological study of dementia senilis & Alzheimer's disease. Psychiatr Neurol (Basel) 1958;136:146–156. doi: 10.1159/000139555. (In French) [DOI] [PubMed] [Google Scholar]
  • 29.Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol. 2011;37:94–113. doi: 10.1111/j.1365-2990.2010.01147.x. [DOI] [PubMed] [Google Scholar]
  • 30.Tikka S, Baumann M, Siitonen M, Pasanen P, Pöyhönen M, Myllykangas L, Viitanen M, Fukutake T, Cognat E, Joutel A, et al. CADASIL and CARASIL. Brain Pathol. 2014;24:525–544. doi: 10.1111/bpa.12181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kalaria RN, Pax AB. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res. 1995;705:349–352. doi: 10.1016/0006-8993(95)01250-8. [DOI] [PubMed] [Google Scholar]
  • 32.Schultz JJ, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest. 2002;109:787–796. doi: 10.1172/JCI0214190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004;63:423–432. doi: 10.1016/j.cardiores.2004.04.030. [DOI] [PubMed] [Google Scholar]
  • 34.Yurovsky VV, Gerzanich V, Ivanova S, Dong Y, Tsymbalyuk O, Simard JM. Autocrine TGF-beta1 mediates angiotensin II-induced proliferative response of cerebral vessels in vivo. Am J Hypertens. 2007;20:950–956. doi: 10.1016/j.amjhyper.2007.03.013. [DOI] [PubMed] [Google Scholar]
  • 35.Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-β signaling in vascular fibrosis. Cardiovasc Res. 2007;74:196–206. doi: 10.1016/j.cardiores.2007.02.008. [DOI] [PubMed] [Google Scholar]
  • 36.Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA. 2008;105:4441–4446. doi: 10.1073/pnas.0709259105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yu F, Swartwood RM. Feasibility and perception of the impact from aerobic exercise in older adults with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2012;27:397–405. doi: 10.1177/1533317512453492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yaffe K. Biomarkers of Alzheimer's disease and exercise: One step closer to prevention. Ann Neurol. 2010;68:275–276. doi: 10.1002/ana.22143. [DOI] [PubMed] [Google Scholar]
  • 39.Geda YE, Roberts RO, Knopman DS, Christianson TJ, Pankratz VS, Ivnik RJ, Boeve BF, Tangalos EG, Petersen RC, Rocca WA. Physical exercise, aging, and mild cognitive impairment: A population-based study. Arch Neurol. 2010;67:80–86. doi: 10.1001/archneurol.2009.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Archer T. Physical exercise alleviates debilities of normal aging and Alzheimer's disease. Acta Neurol Scand. 2011;123:221–238. doi: 10.1111/j.1600-0404.2010.01412.x. [DOI] [PubMed] [Google Scholar]
  • 41.Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, et al. A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease. Contemp Clin Trials. 2012;33:1105–1116. doi: 10.1016/j.cct.2012.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hill KD, LoGiudice D, Lautenschlager NT, Said CM, Dodd KJ, Suttanon P. Effectiveness of balance training exercise in people with mild to moderate severity Alzheimer's disease: Protocol for a randomised trial. BMC Geriatr. 2009;9:29. doi: 10.1186/1471-2318-9-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Etnier JL, Nowell PM, Landers DM, Sibley BA. A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res Brain Res Rev. 2006;52:119–130. doi: 10.1016/j.brainresrev.2006.01.002. [DOI] [PubMed] [Google Scholar]
  • 44.Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. Am J Alzheimers Dis Other Demen. 2011;26:381–388. doi: 10.1177/1533317511418956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, et al. Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year. Arch Gerontol Geriatr. 2013;56:96–103. doi: 10.1016/j.archger.2012.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Suttanon P, Hill KD, Said CM, Williams SB, Byrne KN, LoGiudice D, Lautenschlager NT, Dodd KJ. Feasibility, safety and preliminary evidence of the effectiveness of a home-based exercise programme for older people with Alzheimer's disease: A pilot randomized controlled trial. Clin Rehabil. 2013;27:427–438. doi: 10.1177/0269215512460877. [DOI] [PubMed] [Google Scholar]
  • 47.McArdle WD, Katch FI, Katch VL. Exercise physiology: nutrition, energy, and human performance. Lippincott Williams & Wilkins; Philadelphia, PA: 2010. [Google Scholar]
  • 48.McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: Results of a randomized, controlled trial. J Am Geriatr Soc. 2011;59:1393–1402. doi: 10.1111/j.1532-5415.2011.03519.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Abe K. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;79:1071–1071; author reply 1071. doi: 10.1212/WNL.0b013e31826bd5cf. [DOI] [PubMed] [Google Scholar]
  • 50.Buchman AS, Boyle PA, Yu L, Shah RC, Wilson RS, Bennett DA. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78:1323–1329. doi: 10.1212/WNL.0b013e3182535d35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: An analysis of population-based data. Lancet Neurol. 2014;13:788–794. doi: 10.1016/S1474-4422(14)70136-X. [DOI] [PubMed] [Google Scholar]
  • 52.Pitkälä KH, Pöysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): A randomized controlled trial. JAMA Intern Med. 2013;173:894–901. doi: 10.1001/jamainternmed.2013.359. [DOI] [PubMed] [Google Scholar]
  • 53.Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: A systematic review of prospective evidence. Psychol Med. 2009;39:3–11. doi: 10.1017/S0033291708003681. [DOI] [PubMed] [Google Scholar]
  • 54.Um HS, Kang EB, Koo JH, Kim HT, Jin-Lee Kim EJ, Yang CH, An GY, Cho IH, Cho JY. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neurosci Res. 2011;69:161–173. doi: 10.1016/j.neures.2010.10.004. [DOI] [PubMed] [Google Scholar]
  • 55.Yu F, Kolanowski AM, Strumpf NE, Eslinger PJ. Improving cognition and function through exercise intervention in Alzheimer's disease. J Nurs Scholarsh. 2006;38:358–365. doi: 10.1111/j.1547-5069.2006.00127.x. [DOI] [PubMed] [Google Scholar]
  • 56.Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Rivière D, Vellas B. Exercise program for nursing home residents with Alzheimer's disease: A 1-year randomized, controlled trial. J Am Geriatr Soc. 2007;55:158–165. doi: 10.1111/j.1532-5415.2007.01035.x. [DOI] [PubMed] [Google Scholar]
  • 57.Buschert V, Bokde AL, Hampel H. Cognitive intervention in Alzheimer disease. Nat Rev Neurol. 2010;6:508–517. doi: 10.1038/nrneurol.2010.113. [DOI] [PubMed] [Google Scholar]
  • 58.Cendoroglo MS, Thiessen EJ, Blake CM, Forbes SS, Forbes S. Exercise programs for people with dementia. Sao Paulo Med J. 2014;132:195–196. doi: 10.1590/1516-3180.20141323T2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Scarmeas N, Luchsinger JA, Brickman AM, Cosentino S, Schupf N, Xin-Tang M, Gu Y, Stern Y. Physical activity and Alzheimer disease course. Am J Geriatr Psychiatry. 2011;19:471–481. doi: 10.1097/JGP.0b013e3181eb00a9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Regan C, Katona C, Walker Z, Livingston G. Relationship of exercise and other risk factors to depression of Alzheimer's disease: The LASER-AD study. Int J Geriatr Psychiatry. 2005;20:261–268. doi: 10.1002/gps.1278. [DOI] [PubMed] [Google Scholar]
  • 61.Williams CL, Tappen RM. Exercise training for depressed older adults with Alzheimer's disease. Aging Ment Health. 2008;12:72–80. doi: 10.1080/13607860701529932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Williams CL, Tappen RM. Effect of exercise on mood in nursing home residents with Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2007;22:389–397. doi: 10.1177/1533317507305588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Hernandez SS, Coelho FG, Gobbi S, Stella F. Effects of physical activity on cognitive functions, balance and risk of falls in elderly patients with Alzheimer's dementia. Rev Bras Fisioter. 2010;14:68–74. doi: 10.1590/S1413-35552010000100011. (In Portuguese) [DOI] [PubMed] [Google Scholar]
  • 64.de Andrade LP, Gobbi LT, Coelho FG, Christofoletti G, Costa JL, Stella F. Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: A controlled trial. J Am Geriatr Soc. 2013;61:1919–1926. doi: 10.1111/jgs.12531. [DOI] [PubMed] [Google Scholar]
  • 65.Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, Timson BF, Csernansky JG. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis. 2009;35:426–432. doi: 10.1016/j.nbd.2009.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wolf SA, Kronenberg G, Lehmann K, Blankenship A, Overall R, Staufenbiel M, Kempermann G. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol Psychiatry. 2006;60:1314–1323. doi: 10.1016/j.biopsych.2006.04.004. [DOI] [PubMed] [Google Scholar]
  • 67.Pereira AC, Huddleston DE, Brickman AM, Sosunov AA, Hen R, McKhann GM, Sloan R, Gage FH, Brown TR, Small SA. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA. 2007;104:5638–5643. doi: 10.1073/pnas.0611721104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lange-Asschenfeldt C, Kojda G. Alzheimer's disease, cerebrovascular dysfunction and the benefits of exercise: From vessels to neurons. Exp Gerontol. 2008;43:499–504. doi: 10.1016/j.exger.2008.04.002. [DOI] [PubMed] [Google Scholar]
  • 69.Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF. Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci. 2006;61:1166–1170. doi: 10.1093/gerona/61.11.1166. [DOI] [PubMed] [Google Scholar]
  • 70.Radak Z, Hart N, Sarga L, Koltai E, Atalay M, Ohno H, Boldogh I. Exercise plays a preventive role against Alzheimer's disease. J Alzheimers Dis. 2010;20:777–783. doi: 10.3233/JAD-2010-091531. [DOI] [PubMed] [Google Scholar]
  • 71.Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, Hwang DY, Cho JY. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int J Mol Med. 2008;22:529–539. [PubMed] [Google Scholar]
  • 72.Pérez CA, Cancela Carral JM. Benefits of physical exercise for older adults with Alzheimer's disease. Geriatr Nurs. 2008;29:384–391. doi: 10.1016/j.gerinurse.2007.12.002. [DOI] [PubMed] [Google Scholar]
  • 73.van Praag H, Christie BR, Sejnowski TJ, Gage FH. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA. 1999;96:13427–13431. doi: 10.1073/pnas.96.23.13427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 2011;108:3017–3022. doi: 10.1073/pnas.1015950108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Coelho FG, Vital TM, Stein AM, Arantes FJ, Rueda AV, Camarini R, Teodorov E, Santos-Galduróz RF. Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease. J Alzheimers Dis. 2014;39:401–408. doi: 10.3233/JAD-131073. [DOI] [PubMed] [Google Scholar]
  • 76.Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis. 2011;43:486–494. doi: 10.1016/j.nbd.2011.04.022. [DOI] [PubMed] [Google Scholar]
  • 77.Leem YH, Lee YI, Son HJ, Lee SH. Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23. Biochem Biophys Res Commun. 2011;406:359–365. doi: 10.1016/j.bbrc.2011.02.046. [DOI] [PubMed] [Google Scholar]
  • 78.Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci. 2000;23:639–645. doi: 10.1016/S0166-2236(00)01672-6. [DOI] [PubMed] [Google Scholar]
  • 79.Gottschalk WA, Jiang H, Tartaglia N, Feng L, Figurov A, Lu B. Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn Mem. 1999;6:243–256. [PMC free article] [PubMed] [Google Scholar]
  • 80.Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: A meta-analytic study. Psychol Sci. 2003;14:125–130. doi: 10.1111/1467-9280.t01-1-01430. [DOI] [PubMed] [Google Scholar]
  • 81.Angevaren M, Aufdemkampe G, Verhaar H, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008;3:CD005381. doi: 10.1002/14651858.CD005381.pub3. [DOI] [PubMed] [Google Scholar]
  • 82.Smith PJ, Blumenthal JA, Hoffman BM, Cooper H, Strauman TA, Welsh-Bohmer K, Browndyke JN, Sherwood A. Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials. Psychosom Med. 2010;72:239–252. doi: 10.1097/PSY.0b013e3181d14633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. 2004;20:2580–2590. doi: 10.1111/j.1460-9568.2004.03720.x. [DOI] [PubMed] [Google Scholar]

Articles from Biomedical Reports are provided here courtesy of Spandidos Publications

RESOURCES